Rare diseases
Investigational molecules
Locations
Back to Norway142 clinical trials in Tromsø, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
NorwayStudy of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer
NorwayNorwayStudy on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor
NorwayStudy on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer
NorwayStudy on Cyclophosphamide for Patients with Advanced Breast Cancer with TP53 Mutations
NorwayStudy on Ticagrelor and Acetylsalicylic Acid for Patients with Acute Coronary Syndrome Undergoing Coronary Artery Bypass Grafting
NorwayStudy on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer
NorwayStudy on Paracetamol and Strong Opioids for Pain Relief in Patients with Metastatic Cancer
NorwayStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
NorwayThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on innovative cancer treatments, including research on rare cancers, hepatoblastoma, and testicular cancer. Studies explore personalized treatment approaches and drug efficacy evaluation.
Novel therapeutic strategies and targeted treatments are being investigated to improve patient outcomes.
Research focusing on Alzheimer's disease treatment and acute ischemic stroke management. Studies evaluate new drug comparisons and therapeutic interventions.
Emphasis on developing effective therapeutic approaches for neurodegenerative conditions.
Comprehensive studies addressing various childhood conditions, including acute wheezing, leukemia, and respiratory infections.
Focus on improving treatment outcomes in young patients through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
